RNA targeting using CasRx can prevent aminoglycoside-induced hearing loss
Saved in:
Main Author: | Xavier Bofill-De Ros (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Specific knockdown of Htra2 by CRISPR-CasRx prevents acquired sensorineural hearing loss in mice
by: Yang Guo, et al.
Published: (2022) -
CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses?
by: Diana Perez-SanJose, et al.
Published: (2021) -
Rx
by: Nourse, Alan Edward, 1928-1992; Emshwiller, Ed, 1925-1990 [Illustrator] -
Toward learning the rules that predict siRNA efficacy
by: Xavier Bofill-De Ros
Published: (2023) -
Restoration of microRNA metabolism trigger robust antitumor responses
by: Xavier Bofill-De Ros
Published: (2022)